文献
J-GLOBAL ID:201702239107359988
整理番号:17A1562449
ヒト血しょうにおけるリボヌクレオチドレダクターゼ阻害剤トリアピンの定量のためのLC-MS/MSアッセイ【Powered by NICT】
LC-MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasma
著者 (17件):
Matsumoto Julia
(Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States)
,
Matsumoto Julia
(School of Pharmaceutical Sciences, Sao Paulo State University, Araraquara, SP, Brazil)
,
Kiesel Brian F.
(Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States)
,
Kiesel Brian F.
(Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States)
,
Parise Robert A.
(Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States)
,
Guo Jianxia
(Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States)
,
Taylor Sarah
(Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Medicine, University of Pittsburgh-Magee Women’s Hospital, Pittsburgh, PA, United States)
,
Huang Marilyn
(Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Medicine, University of Pittsburgh-Magee Women’s Hospital, Pittsburgh, PA, United States)
,
Eiseman Julie L.
(Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States)
,
Eiseman Julie L.
(Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States)
,
Ivy S. Percy
(Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States)
,
Kunos Charles
(Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, United States)
,
Chu Edward
(Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States)
,
Chu Edward
(Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States)
,
Beumer Jan H.
(Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States)
,
Beumer Jan H.
(Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States)
,
Beumer Jan H.
(Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States)
資料名:
Journal of Pharmaceutical and Biomedical Analysis
(Journal of Pharmaceutical and Biomedical Analysis)
巻:
146
ページ:
154-160
発行年:
2017年
JST資料番号:
H0876A
ISSN:
0731-7085
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)